Old Web
English
Sign In
Acemap
>
authorDetail
>
Hitoshi Miyashita
Hitoshi Miyashita
Takeda Pharmaceutical Company
Molecular biology
Biology
Immunology
Leukemia
Transdifferentiation
4
Papers
83
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Prolyl-tRNA synthetase inhibition promotes cell death in SK-MEL-2 cells through GCN2-ATF4 pathway activation.
2017
Biochemical and Biophysical Research Communications
Takeo Arita
Megumi Morimoto
Yukiko Yamamoto
Hitoshi Miyashita
Satoshi Kitazawa
Takaharu Hirayama
Sou Sakamoto
Kazumasa Miyamoto
Ryutaro Adachi
Misa Iwatani
Takahito Hara
Show All
Source
Cite
Save
Citations (7)
Synergistic anti-AML effects of the LSD1 inhibitor T-3775440 and the NEDD8-activating enzyme inhibitor pevonedistat via transdifferentiation and DNA rereplication
2017
Yoshinori Ishikawa
Kazuhide Nakayama
Megumi Morimoto
A. Mizutani
A. Nakayama
Kosei Toyoshima
A. Hayashi
Shinji Takagi
Ryo Dairiki
Hitoshi Miyashita
Satoru Matsumoto
Kanae Gamo
Toshiyuki Nomura
Kazuhide Nakamura
Show All
Source
Cite
Save
Citations (19)
A novel LSD1 inhibitor T-3775440 disrupts GFI1B-containing complex leading to transdifferentiation and impaired growth of AML cells.
2017
Molecular Cancer Therapeutics
Yoshinori Ishikawa
Kanae Gamo
Masato Yabuki
Shinji Takagi
Kosei Toyoshima
Kazuhide Nakayama
Akiko Nakayama
Megumi Morimoto
Hitoshi Miyashita
Ryo Dairiki
Yukiko Hikichi
Naoki Tomita
Daisuke Tomita
Shinichi Imamura
Misa Iwatani
Yusuke Kamada
Satoru Matsumoto
Ryujiro Hara
Toshiyuki Nomura
Ken Tsuchida
Kazuhide Nakamura
Show All
Source
Cite
Save
Citations (56)
Abstract A207: Discovery of molecular mechanisms underlying cellular sensitivity to the PLK1 inhibitor TAK-960.
2011
Molecular Cancer Therapeutics
Kohei Honda
Isao Kaieda
Koki Hikami
Hitoshi Miyashita
Yusuke Nakayama
Koji Yamamoto
Hisashi Anayama
Yuichi Hikichi
Keisuke Kuida
Erik Kupperman
Show All
Source
Cite
Save
Citations (1)
1